(lp0
S'Oculus Innovative Sciences Announces Corporate Name Change to Sonoma ... GlobeNewswire  - Dec 5, 2016 PETALUMA, Calif., Dec. 05, 2016  -- Oculus Innovative Sciences, Inc. , a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and&nbsp;...'
p1
aS'Sonoma Pharmaceuticals Announces Results from SebuDerm Gel Study in ... GlobeNewswire  - Mar 16, 2017 PETALUMA, Calif., March 16, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of&nbsp;...'
p2
aS"Sonoma Pharmaceuticals Inc. MarketWatch - Jan 1, 2017 Welcome to your new quote page. We're hard at work to transition all ticker pages to this new look and feel. Have questions or concerns?"
p3
aS'Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2017 Financial Results ... GlobeNewswire  - Jan 26, 2017 PETALUMA, Calif., Jan. 26, 2017  -- Sonoma Pharmaceuticals, Inc. , today announced that the financial results for its fiscal third quarter 2017, ended December 31, 2016, will be released after the U.S.'
p4
aS'BRIEF-Oculus Innovative Sciences announces corporate name change to Sonoma ... Reuters - Jun 29, 2015 MOSCOW, March 18 The Russian lower house of parliament, the State Duma, has approved a proposal to launch an investigation into U.S.'
p5
aS'Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 GlobeNewswire  - Feb 9, 2017 09, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced&nbsp;...'
p6
aS'Chart Watch: Checking on Shares of Sonoma Pharmaceuticals Inc  Baxter Review - Mar 20, 2017 Technical traders have a large inventory of technical indicators they may use when doing technical stock analysis. After a recent look, the 14-day ATR for Sonoma Pharmaceuticals Inc  is resting at 0.33. First developed by J. Welles Wilder, the ...'
p7
aS'Sonoma Pharmaceuticals Inc  Given Average Rating of Strong Buy by ... The Cerbat Gem - Mar 12, 2017 Sonoma Pharmaceuticals logo Sonoma Pharmaceuticals Inc  has earned an average broker rating score of 1.00  from the one analysts that cover the company, Zacks Investment Research reports.'
p8
aS'Zacks: Sonoma Pharmaceuticals Inc  Given Consensus Recommendation of ... Chaffey Breeze - Mar 10, 2017 Sonoma Pharmaceuticals logo Shares of Sonoma Pharmaceuticals Inc  have been assigned an average broker rating score of 1.00  from the one brokers that cover the stock, Zacks Investment Research reports.'
p9
aS'BRIEF-Sonoma Pharmaceuticals reports financial results for fiscal Q3 2017 Reuters - Feb 9, 2017 Feb 27 La Jolla Pharmaceutical Co said its lead experimental drug to treat low blood pressure met the main goal of a late-stage study on patients with distributive shock who have not adequately responded to existing treatments.'
p10
a.